Australia's largest stock trading and investment forum Australia's #1 stock forum

GMV

Click for more information

0.00%

3.9¢ g medical innovations holdings limited

GMVD Nasdaq, page-69

First 69 Last

Share
Profile

Follow
OgdensNut

22 Posts.

4

13/09/21

11:00

Post #: 56014887
Share

Originally posted by Galilee13: ↑

Hi HonyakuKonyaku

You raise another interesting point, and in general is more about the BS fluffy announcements Gmed has made during its life. All talk and no substance.

In regards to the university hospitals deal, I have been pushing Gmed on this for quiet sometime. As we all know this was to increase patient numbers three fold or by about 84,000 per year. On my numbers and using an average patient price of $220, this deal alone could be generating about $18m a year in revenue. Gmed also put out a release back in August stating that the IDTF business processed 4,000 patients during the month of July 2020. Again using an average price of $220, by the companies own announcements that’s $880k a month or $10m a year in revenue.

We all know this has turned out to be complete BS. So what happened?

After many emails to Gmed staff and directors I finally got a response from the Chairman Kenneth Melani who stated that the university hospitals deal and all the other distribution agreements were subject to raising additional capital from the Nasdaq IPO. Basically Gmed had no capital to execute these deals. He pointed me to the balance sheet and $650k c note deal in April that the company had no money to fund growth.

So, IMO don’t expect revenue to increase when the company releases June 30 numbers. The best we can hope for is an update on these deals and agreements. Now the company has the capital, as per Kenneth, the company should be able to execute these deals. This is evident from the fact the prizma is available on the Livecare website and network. He also pointed me to the FWP and the fact the company is using the IPO funds to growth the business vis the university hospitals deal, Livecare and Oschsner Health. All are mentioned in the F1.

I have also been communicating with the new IR Kevin. He tells me that the company will not be holding a conference call and the update “may” include an update on business activities. He also tells me Gmed is targeting some healthcare investor conferences in September.

Again, it’s all talk until we see come cash in the bank. I remain hopefully that the company has pull a rabbit out of a hat and increase revenue. If it can we should see a significant rerate of the share price just in time for pie shares to come out of restriction.

Expand

Hi Galilee, thanks for sharing your information, and for your comments - much appreciated!

I know we all feel this, but I'm absolutely gobsmacked by Kenneth Melani's response about the hospital deals being subject to a capital raising or IPO. What a load of BS! Their "Trumpian" reporting on this (and just about everything else they've ever reported) comes across as a complete stuff up at best, or deliberately misleading at worst. Reminds me of this very interesting article about the difference between lies, BS and fake news https://link.springer.com/article/10.1007/s42438-018-0025-4. I'm not sure I've ever seen such an unashamedly contemptuous attitude to shareholders.

Whilst I acknowledge that hope is not a strategy, it appears that is all we have left...

Last edited by OgdensNut: 13/09/21

GMV Price at posting: 3.9¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Making money: How many microcaps should be in an investor's portfolio?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

There are more pages in this discussion • 759 more messages in this thread...

First 69 Last

Add GMV (ASX) to my watchlist